Health Care & Life Sciences » Pharmaceuticals | Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
45,812
64,029
65,706
90,479
-
-
Depreciation, Depletion & Amortization
4,092
11,947
10,375
12,648
-
-
Other Funds
11,399
-
26
30
-
-
Funds from Operations
39,271
53,983
65,259
75,362
36,614
-
Changes in Working Capital
2,071
392
2,468
4,092
-
-
Net Operating Cash Flow
41,342
53,591
67,726
71,270
-
-
Capital Expenditures
9,060
23,659
34,035
36,929
-
Sale of Fixed Assets & Businesses
89
503
706
1,025
-
Purchase/Sale of Investments
11,338
49
4,097
8,729
-
Net Investing Cash Flow
25,647
29,594
47,598
46,002
-
Cash Dividends Paid - Total
6,055
3,633
8,687
2,889
-
Issuance/Reduction of Debt, Net
22,749
5,479
6,781
10,721
-
Net Financing Cash Flow
5,295
8,363
15,871
19,516
-
Net Change in Cash
22,896
16,751
8,482
6,107
-
Free Cash Flow
32,282
29,933
33,691
34,341
-
Net Assets from Acquisitions
-
3,195
10,256
1,672
-
Other Sources
8,849
3,727
5,130
6,807
-
Change in Capital Stock
-
749
378
27,317
-
Exchange Rate Effect
1,906
1,116
4,225
355
-
Other Uses
14,188
6,921
5,046
6,505
-

About Sun Pharmaceutical Industries

View Profile
Address
CTS No. 201 B/1, Sun House
Mumbai Maharashtra 400063
India
Employees -
Website http://www.sunpharma.com
Updated 07/08/2019
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It operates through the following geographical segments: India, United States of America, Emerging Markets, and Rest of the World. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.